20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Penumbra Inc (PEN) operates in the MEDICAL DEVICES industry and is headquartered in Alameda, United States with about 4,700 employees. Its market capitalization is roughly $13 billion. In the fiscal year ended 2025-12-31, PEN reported $1.4B in revenue and $178M in net income.
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally.
Interactive charts & full statements → Open the PEN valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1.5B | $1.4B | $1.2B | $1.1B | $847M | $748M | $560M | $547M | $445M | $334M | $263M | $186M | $126M | $89M | $73M |
| Gross Profit | $1.0B | $942M | $755M | $683M | $535M | $475M | $338M | $372M | $293M | $217M | $171M | $124M | $83M | $58M | $49M |
| Gross Margin % | 67.8% | 67.1% | 63.2% | 64.5% | 63.2% | 63.6% | 60.3% | 68.0% | 65.8% | 65.1% | 64.9% | 66.7% | 66.0% | 65.1% | 66.9% |
| Operating Income (EBIT) | $187M | $189M | $9M | $74M | $6M | ($8M) | ($39M) | $48M | ($1M) | $1M | ($1M) | $4M | $3M | ($1M) | $3M |
| Operating Margin % | 12.4% | 13.5% | 0.8% | 7.0% | 0.7% | -1.0% | -7.0% | 8.7% | -0.2% | 0.4% | -0.5% | 2.2% | 2.4% | -1.3% | 4.7% |
| Net Income | $161M | $178M | $14M | $91M | ($2M) | $3M | ($19M) | $48M | $7M | $5M | $15M | $2M | $2M | $4M | $2M |
| Net Margin % | 10.7% | 12.7% | 1.2% | 8.6% | -0.2% | 0.4% | -3.4% | 8.8% | 1.5% | 1.4% | 5.6% | 1.3% | 1.8% | 4.6% | 2.7% |
| EBITDA | — | $223M | $46M | $109M | $30M | $9M | ($26M) | $56M | $36M | $5M | $1M | $6M | $4M | $0M | $3M |
| Earnings Per Share (EPS) | $4.07 | $4.52 | $0.36 | $2.32 | $-0.05 | $0.07 | $-0.54 | $1.34 | $0.18 | $0.13 | $0.44 | $0.17 | $0.09 | $0.17 | $0.08 |
| Shares Outstanding (M) | — | 39M | 39M | 39M | 38M | 38M | 36M | 36M | 36M | 35M | 33M | 14M | 25M | 25M | 25M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $390M | $375M | $385M | $355M | $339M | $324M | $316M | $301M | $299M |
| Gross Profit | $265M | $253M | $262M | $240M | $224M | $216M | $211M | $200M | $163M |
| Gross Margin % | 68.0% | 67.6% | 68.0% | 67.8% | 66.0% | 66.6% | 66.8% | 66.5% | 54.4% |
| Operating Income (EBIT) | $41M | $38M | $59M | $49M | $41M | $40M | $43M | $35M | ($81M) |
| Operating Margin % | 10.5% | 10.2% | 15.4% | 13.8% | 12.0% | 12.4% | 13.6% | 11.8% | -27.0% |
| Net Income | $35M | $33M | $47M | $46M | $45M | $39M | $34M | $30M | ($60M) |
| Net Margin % | 9.0% | 8.7% | 12.3% | 12.9% | 13.3% | 12.1% | 10.7% | 9.8% | -20.1% |
| EBITDA | — | $47M | $68M | $55M | $51M | $49M | $49M | $44M | ($70M) |
| Earnings Per Share (EPS) | $0.88 | $0.82 | $1.20 | $1.17 | $1.15 | $1.00 | $0.86 | $0.75 | $-1.55 |
| Shares Outstanding (M) | — | 40M | 39M | 39M | 39M | 39M | 39M | 39M | 39M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $277M | $239M | $168M | $97M | ($56M) | $10M | ($33M) | $27M | $29M | $13M | ($13M) | ($22M) | ($6M) | ($3M) |
| Capital Expenditures (CapEx) | $62M | $64M | $21M | $15M | $19M | $21M | $25M | $22M | $10M | $15M | $14M | $5M | $4M | $1M |
| Free Cash Flow (FCF) | $215M | $175M | $147M | $82M | ($75M) | ($12M) | ($58M) | $5M | $19M | ($2M) | ($26M) | ($28M) | ($10M) | ($4M) |
| FCF Margin % | 14.3% | 12.5% | 12.3% | 7.8% | -8.8% | -1.6% | -10.3% | 0.8% | 4.3% | -0.7% | -10.0% | -14.9% | -8.2% | -4.7% |
| Dividends Paid | — | — | — | — | $8M | $16M | $10M | $19M | — | $0M | $0M | $0M | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $46M | $87M | $86M | $58M | $45M | $49M | $51M | $56M | $23M |
| Capital Expenditures (CapEx) | $14M | $14M | $18M | $16M | $16M | $13M | $5M | $5M | $5M |
| Free Cash Flow (FCF) | $32M | $73M | $68M | $42M | $29M | $36M | $46M | $51M | $18M |
| FCF Margin % | 8.2% | 19.6% | 17.7% | 11.8% | 8.6% | 10.9% | 14.5% | 17.0% | 6.0% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.0B | $1.8B | $1.5B | $1.6B | $1.4B | $1.2B | $823M | $666M | $515M | $477M | $308M | $264M | $121M | $71M |
| Cash & Cash Equivalents | $205M | $187M | $324M | $167M | $70M | $59M | $70M | $73M | $68M | $51M | $13M | $20M | $3M | $4M |
| Total Liabilities | $444M | $399M | $382M | $377M | $372M | $290M | $185M | $180M | $93M | $76M | $42M | $31M | $134M | $79M |
| Total Debt (Short + Long-Term) | — | $16M | $15M | $13M | $12M | $10M | $6M | $8M | $0M | $0M | $0M | $0M | $0M | $6M |
| Total Shareholders' Equity | $1.5B | $1.4B | $1.2B | $1.2B | $999M | $954M | $641M | $486M | $422M | $400M | $267M | $233M | ($12M) | ($8M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PEN viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms